Abstract

Case Report

COVID-19 and rhino-orbital mucormycosis – a case report

Dilbag Singh*, Harveen Kaur and NC Kajal

Published: 05 October, 2021 | Volume 5 - Issue 1 | Pages: 094-096

There is a constant rise in cases of rhino-orbital mucormycosis in people with Coronavirus disease 2019 (COVID-19). Generally, Mucormycosis develops in immunosuppression or debilitating diseases. In cases having head and neck involvement, the mold enters the respiratory tract with further involvement of nose and sinuses and there is consecutive progression into orbital and intracranial structures. Diabetes Mellitus (DM) is an independent risk factor for both severe COVID-19 and mucormycosis. The clinical examination and direct smears are helpful for early diagnosis of the disease and timely intervention. For the better prevention and management of such opportunistic infections in COVID-19 patients, it is prudent to establish prophylactic treatment protocols along with rational use of corticosteroids. We here report a case of Rhino-orbital Mucormycosis infection caused by Rhizopus oryzae in a COVID-19 patient with Diabetes Mellitus.

Read Full Article HTML DOI: 10.29328/journal.jprr.1001032 Cite this Article Read Full Article PDF

Keywords:

COVID-19; Diabetes Mellitus (DM); Mucormycosis; Amphotericin B

References

  1. Jayaweera M, Perera H, Gunawardana B, Manatunge J. Transmission of COVID-19 virus by droplets and aerosols: a critical review on the unresolved dichotomy. Environ Res. 2020; 188: 109819. PubMed: https://pubmed.ncbi.nlm.nih.gov/32569870/
  2. Superinfections and coinfections in COVID-19. MedPage Today. https://www.medpagetoday.com/infectiousdisease/covid19/86192
  3. Methylprednisolone for patients with COVID-19 severe acute respiratory syndrome. https://clinicaltrials.gov/ct2/show/NCT04323592
  4. Talmi YP, Goldschmied-Reouven A, Bakon M, Barshack I, Wolf M, et al. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg. 2002; 127: 22-31. PubMed:https://pubmed.ncbi.nlm.nih.gov/12161726/
  5. Chander J, Kaur M, Singla N, Punia R, Singhal S, Attri A, et al. Mucormycosis: battle with the deadly enemy over a five-year period in India. J Fungi. 4: 46. PubMed:https://pubmed.ncbi.nlm.nih.gov/29642408/
  6. Deutsch PG, Whittaker J, Prasad S. Invasive and non-invasive fungal rhinosinusitis—a review and update of the evidence. Medicina. 2019; 55: 1-14. PubMed:https://pubmed.ncbi.nlm.nih.gov/31261788/
  7. Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med. 2021; 42: 264. PubMed: https://pubmed.ncbi.nlm.nih.gov/32972795/
  8. Gupta S, Goyal R, Kaore NM. Rhino-orbital-cerebral mucormycosis: battle with the deadly enemy. Indian J Otolaryngol Head Neck Surg. 2020; 72: 104-111. PubMed:https://pubmed.ncbi.nlm.nih.gov/32158665/
  9. Parsi K, Itgampalli RK, Vittal R, Kumar A. Perineural spread of rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans. Ann Indian Acad Neurol. 2013; 16: 414-417. PubMed: https://pubmed.ncbi.nlm.nih.gov/24101833/

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More